Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genomic-guided Chemotherapy in Advanced Gastric Cancer (3G)
NCT01100801Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Jul 2010
- Primary completion
- Dec 2017
- Modality
- Reversible Covalent Inhibitors, DNA Intercalators/Alkylators, Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur + gimeracil + oteracil, cisplatin, oxaliplatin in gastric cancer (GC), sponsored by National University Hospital. Status: unknown.
02
Drugs
tegafur + gimeracil + oteracilcisplatinoxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01100801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100801.